Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Johnson & Johnson
Current Parent CompanyJohnson & Johnson
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $541,000,000
Year: 2013
Date: November 4, 2013
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: kickbacks and bribery
Mega-ScandalImproper Drug Marketing
Violation Description: Johnson & Johnson and its subsidiaries agreed to pay $541 million to resolve multistate litigation alleging unlawful marketing practices, including off-label promotion and kickbacks, to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. The off-label marketing accounted for $524 million; the other $17 million resolved allegations that J&J subsidiary Janssen paid kickbacks to nuring home pharmacy Omnicare. All of this was part of a larger $2.2 billion civil and criminal settlement involving the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.